Latest papers

Effects of breast-conserving therapy on lactation after pregnancy.

Dose-dense sequential adriamycin-Paclitaxel-cyclophosphamide chemotherapy is well tolerated and safe in high-risk early breast cancer.

Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray.

A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer.

DNA hypomethylation is prevalent even in low-grade breast cancers.

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.

Antioxidative response for nitric oxide production in breast carcinoma.

Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.

Breast cancer in young women ( or = 35 years): Genomic aberrations detected by comparative genomic hybridization.

Expression of TRAG-3 in breast cancer.

Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer.

Tissue and serum MUC1 mucin detection in breast cancer patients.

Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients.

Risk factors for colorectal cancer following breast cancer.

Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.

Missed breast carcinoma: pitfalls and pearls.

Molecular genetics and histopathologic features of adult distal nephron tumors.